Market revenue in 2022 | USD 179.7 million |
Market revenue in 2030 | USD 346.3 million |
Growth rate | 8.5% (CAGR from 2022 to 2030) |
Largest segment | Transmitter & receiver |
Fastest growing segment | Insulin Pumps |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Sensors, Transmitter & Receiver, Insulin Pumps |
Key market players worldwide | DexCom Inc, Abbott Laboratories, Medtronic PLC, Ypsomed Holding AG, Senseonics Holdings Inc, A.Menarini Diagnostics, Signos |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to continuous glucose monitoring devices market will help companies and investors design strategic landscapes.
Transmitter & receiver was the largest segment with a revenue share of 37.01% in 2022. Horizon Databook has segmented the France continuous glucose monitoring devices market based on sensors, transmitter & receiver, insulin pumps covering the revenue growth of each sub-segment from 2018 to 2030.
Diabetes stands out as the most prevalent chronic condition, fully covered by France’s Statutory Health Insurance (SHI), with the number of covered patients doubling over the last decade. According to WHO, France has approximately one million diagnosed cases of diabetes.
The prevalence of diabetes across all age groups in France is surging due to a rising obese population, unhealthy dietary habits, and sedentary lifestyles. Moreover, the growing incidence of diabetes & obesity, rising awareness of diabetic care, healthcare expenditure, and technological advancements contribute to market growth.
The country operates a centralized healthcare system, where reimbursement decisions are made at a national level and applied uniformly. For diabetes technological devices in France, reimbursement is determined by the tariff system.
Horizon Databook provides a detailed overview of country-level data and insights on the France continuous glucose monitoring devices market , including forecasts for subscribers. This country databook contains high-level insights into France continuous glucose monitoring devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account